Cargando…
Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?
BACKGROUND: To evaluate alterations in the serum concentrations of vascular endothelial growth factor (VEGF) and netrin-1 after intravitreal bevacizumab (BCZ) injection for the treatment of diabetic macular edema (DME). METHODS: This prospective case-control study included a total of 50 participants...
Autores principales: | Okutucu, Murat, Fındık, Hüseyin, Aslan, Mehmet Gökhan, Arpa, Medeni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167956/ https://www.ncbi.nlm.nih.gov/pubmed/34058994 http://dx.doi.org/10.1186/s12886-021-01989-1 |
Ejemplares similares
-
Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema: A prospective, randomized comparative study
por: Kucukevcilioglu, Murat, et al.
Publicado: (2015) -
Effects of intravitreal injection of netrin-1 in retinal neovascularization of streptozotocin-induced diabetic rats
por: Yu, Yao, et al.
Publicado: (2015) -
Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007) -
Case of endophthalmitis following intravitreal injections of bevacizumab
por: Komori, Shinya, et al.
Publicado: (2010) -
Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)